Ben Sasse is on extended time. He credits "providence, prayer and a miracle drug."
Summary
Ben Sasse, former U.S. senator from Nebraska, was diagnosed with stage 4 pancreatic cancer and given three to four months to live. He credits his longer survival to a clinical trial drug that has significantly shrunk his tumors and is discussing his experience and outlook in a TV interview.Key Facts
- Ben Sasse was diagnosed with stage 4 metastatic pancreatic cancer in December.
- Doctors told him he had three to four months to live initially.
- He is participating in a clinical trial for a drug called daraxonrasib by Revolution Medicines.
- The drug has reduced his tumors by 76%.
- Patients on this drug normally live about 13 months, longer than the usual six months.
- Sasse appeared in an interview on "60 Minutes" discussing his health, family, faith, and politics.
- He expressed concern that Congress is not focusing on long-term problems for the years 2030 and 2050.
- The extended interview will be available on Paramount+, CBSNews.com, and YouTube.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.